VANESSA MIZAK: Open Payments
NPI 1669860979 · CORVALLIS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 5 payments from 4 companies in 2025. Trend: 2023 $1,231 · 2024 $381 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: FASENRA, OFEV, NUCALA, DUPIXENT.
Industry payments across OR — which companies pay providers there.
